US 9518259
Compounds and methods for modulating interaction between proteins and target nucleic acids
granted A61PA61P21/00A61P35/00
Quick answer
US patent 9518259 (Compounds and methods for modulating interaction between proteins and target nucleic acids) held by Ionis Pharmaceuticals, Inc. expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P21/00, A61P35/00